Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 1;21(2):309-314.
doi: 10.17392/1726-21-02. Online ahead of print.

Less invasive surfactant administration versus intubation-surfactant-extubation in preterm infants: a retrospective study

Gianluca Dini  1 , Maria Grazia Santini  1 , Federica Celi  1 , Alberto Verrotti  2
Affiliations
Free article

Less invasive surfactant administration versus intubation-surfactant-extubation in preterm infants: a retrospective study

Gianluca Dini et al. Med Glas (Zenica). .
Free article

Abstract

Aim: To compare the need for intubation and mechanical ventilation after surfactant delivery between less invasive surfactant administration (LISA)-treated and intubation-surfactant-extubation (IN-SURE)-treated premature infants with respiratory distress syndrome (RDS).

Methods: Retrospective registry-based cohort study enrolled 36 newborns admitted to the Neonatal Intensive Care Unit of the "Santa Maria" Hospital of Terni between 2016 and 2023. As a primary outcome, the need for intubation and mechanical ventilation within 72 hours of life was followed, and major neonatal morbidities and death before discharge as the secondary outcome.

Results: The LISA group and the IN-SURE group included 13 and 23 newborns, respectively. Demographic features showed no significant differences between the two groups. The need for mechanical ventilation in the first 72 hours of life was similar in both groups (p>0.99). There were no significant differences in morbidities.

Conclusion: LISA and INSURE are equally effective modalities for surfactant administration for the treatment of RDS in preterm infants.

Keywords: newborn; respiratory distress syndrome; surfactant.

PubMed Disclaimer